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ABSTRACT
Objective To assess whether equity exists in access to
renal transplantation in the UK after adjustment for case
mix in incident patients with end stage renal disease.
Design Longitudinal cohort study.
Setting UK Renal Registry and UK Transplant Registry.
Participants All incident renal replacement treatment
patients (n=16202) from 65 renal centres submitting
datatotheUKRenalRegistrybetween1January2003and
31 December 2005, followed until 31 December 2008 (or
until transplantation or death, whichever was earliest).
Outcome measures Proportion of incident dialysis
patients at each renal centre who were registered on the
national transplant list; time taken to achieve
registration; and proportion of patients subsequently
transplanted.
Results We found that recipients’ age, ethnicity, and
primary renal diagnosis were associated with the
likelihood of accessing the waiting list or receiving a
transplant. After adjustment for case mix, significant
inter-centre variability existed in access to the transplant
list (change in −2LogL=89.9, df=1, P<0.001), in the time
taken to register patients on the waiting list (change in
−2LogL=247.4, df=64, P<0.001), in receipt of a renal
transplant from a donorafter brain stem death (change in
−2LogL=15.1, df=1, P=0.001), and in receipt of a renal
transplant from a living donor or a donor after cardiac
death (change in −2LogL=46.1, df=1, P<0.001).
Conclusions Significant variation in access to renal
transplantation exists between centres within the UK that
cannot be explained by differences in case mix.
INTRODUCTION
Forsuitablepatientswithendstagerenaldisease,renal
transplantation is accepted as the optimal modality of
renal replacement treatment, conferring both better
quality of life and better life expectancy than dialysis.
However, deciding which patients are “suitable” for
renaltransplantationrequiresanindividualisedassess-
ment of the risks of transplantation as well as the likely
benefit. A renal transplant may be obtained from a
donor after brain stem death, a donor after cardiac
death,oralivingkidneydonor.Toobtainarenaltrans-
plantfromadonorafterbrainstemdeath,patientswith
end stage renal disease need to be registered on the
national transplant list. Once registered, individual
patientsareofferedatransplantaccordingtoanational
allocation algorithm (www.uktransplant.org.uk/ukt/
about_transplants/organ_allocation/kidney_(renal)/
kidney_(renal).jsp). Transplantation from a living kid-
ney donor requires that potential donors are identified
andmedicallyevaluated.Finally,transplantationfrom
a donor after cardiac death in the United Kingdom is
predominantly locally resourced, and allocation of
organs is controlled by local centres’ policies. The
probability of receiving a transplant from a donor
after brain stem death once a patient is on the waiting
list is thus predominantly under the influence of
national organ allocation algorithms, whereas the
probability of receiving a transplant from a donor
after cardiac death or a living kidney donor is predo-
minantly influenced by individual centres’ policies
and patterns of practice.
Many patient specific factors including age, sex,
ethnicity,andcomorbidityhavebeenreportedtoinflu-
ence access to kidney transplantation in countries out-
side the UK.
1-10 In the United States, insurance status
has also been reported as an independent predictive
variable determining access to the renal transplant
list.
11 Although general guidelines for the assessment
ofpatients’suitabilityfortransplantationareavailable,
individual clinicians’ and centres’ practices may vary
in the interpretation of these guidelines. Studies
examining centre specific differences in access to
renal transplantation are limited.
12 Within the UK, a
significant effect of centre on the likelihood of being
putonthewaitinglistforrenaltransplantationforinci-
dentpatientsinScotlandandamongprevalentdialysis
patients in England and Wales has been described.
1314
Finally, whether differences exist between centres that
influence the likelihood of subsequent kidney trans-
plantation in patients registered on the national trans-
plant list is not known.
Time ondialysis isrecognised asan important prog-
nostic factor that adversely influences the survival of
grafts and patients after transplantation.
15 The time
taken to register a suitable patient on the transplant
waiting list is mainly influenced by a centre’s practice
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diagnosis of end stage renal disease to activation of
the patient on the transplant list. Furthermore, time
spentonthenationaltransplantlistisanimportantfac-
torinfluencingallocationofdeceaseddonorkidneysin
theUKonthebasisofthe allocationalgorithm.There-
fore, patients who are activated on the list at an early
stage accrue more waiting time credit than do patients
listedlater intheirdialysiscareer.Centresthat achieve
earlier listing thus provide an advantage for their
patients compared with centres that take longer.
Wesetouttoevaluatewhetherequityofaccesstothe
renal transplant list exists for patients with end stage
renal disease across the UK, whether centres differ in
the time taken to activate suitable patients on the wait-
ing list, and whether equity exists in the receipt of a
renal transplant once the patient is on the transplant
list (that is, the conversion efficiency from being on
the waiting list to receiving a transplant). We analysed
patient specific and independent variables that influ-
enced access to the waiting list or transplantation.
METHODS
Study population
We considered for inclusion all patients starting renal
replacement treatment (n=16202) between 1 January
2003 and 31 December 2005 in renal centres returning
datatotheUKRenalRegistry(n=65).Fortheanalysisof
theproportionincludedonthewaitinglist,weexcluded
patientsaged65yearsorabove(n=8210),inappropriate
activation with early suspension as described below
(n=106), and patients listed for multi-organ transplants
otherthanpancreas(n=23),resultinginafinalcohortof
7863patients.Wefollowedallpatientsto31December
2007oruntiltheywereputonthewaitinglistforkidney
transplant alone, kidney plus pancreas transplant, or
death, whichever was earliest. For the analysis of the
proportion transplanted, we followed all patients from
the incident cohort who were activated on the waiting
listbefore31December2006(n=4061)until31Decem-
ber2008,toestimatetheproportiontransplantedwitha
kidney alone or kidney plus pancreas within two years
of inclusion on the waiting list.
We excluded patients aged 65 years or above
because only a small proportion (6%) of the 8210
patients aged 65 or older who started dialysis in 2003-
5 were ever subsequently activated on the transplant
list. We considered only centres contributing data to
the UK Renal Registry for inclusion because we had
no reliable mechanism for identifying or recording
the patient level data we needed for patients starting
renal replacement treatment in units (n=7) not linked
to the registry. Previous analysis at the UK Renal Reg-
istry (David Ansell, personal communication, 2002)
hadfoundthatseveralcentreshadapracticeofactivat-
ing patients on the transplant list followed by immedi-
ate suspension before more permanent activation at a
later date after more formal medical assessment of the
patient’s fitness. We therefore excluded patients who
were suspended for more than 30 days within 90 days
of first activation to prevent this activation practice
influencing the results.
Information on start date of renal replacementtreat-
ment and relevant patient level data including age
(grouped as 18-29, 30-39, 40-49, 50-59, and ≥60), sex,
ethnicity (white, non-white, and missing), and primary
renal diagnosis (diabetes, non-diabetes, and missing)
came from the UK Renal Registry; the date of activa-
tion on the waiting list, date of transplantation, or both
came from the UK Transplant Registry held by the
Organ Donation and Transplantation Directorate of
NHS Blood and Transplant. The UK Renal Registry
is part of the Renal Association, a registered charity
established for the development of care of patients
withrenaldisease.Theregistryactsasasourceofcom-
parative data for audit, benchmarking, planning, pol-
icy,andresearch.TheUKRenalRegistryisfundedby
Table 1 |Results of logistic regression modelling for probability of activation on waiting list
within two years of start of renal replacement treatment
Baseline factor No Odds ratio (95%CI) P value
Age (years):
18-29 766 1 (referent) NA
30-39 1215 0.75 (0.61 to 0.93) 0.007
40-49 1841 0.50 (0.41 to 0.61) <0.001
50-59 2448 0.25 (0.20 to 0.30) <0.001
60-64 1593 0.11 (0.09 to 0.13) <0.001
Ethnicity:
White 4908 1 (referent) NA
Non-white 1284 0.85 (0.74 to 0.97) 0.02
Missing 1671 0.74 (0.66 to 0.84) <0.001
Sex:
Male 4748 1 (referent) NA
Female 3115 0.98 (0.89 to 1.09) 0.75
Primary renal diagnosis:
Non-diabetes 5765 1 (referent) NA
Diabetes 1757 0.40 (0.36 to 0.45) <0.001
Missing 341 0.55 (0.43 to 0.69) <0.001
NA=not applicable.
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Fig 1 | Percentage registered for transplantation within two
years of starting renal replacement treatment. Risk adjusted
for effect of recipient’s age, sex, ethnicity, and primary renal
diagnosis
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capitationfeepaidbytherenalcentressubmittingdata.
The Organ Donation and Transplant Directorate is a
national body that administers organ donation and
transplantation across the UK and records relevant
information on patients on the waiting list as well as
details of transplantation.
Statistical analyses
We developed a logistic regression model to identify
theinfluenceofpatientspecificvariablesincludingage,
sex,ethnicity,andprimaryrenaldiagnosisontheprob-
ability of access to the transplant list and receipt of a
transplant once on the waiting list. After adjusting for
patient specific variables, we determined the percen-
tage of patients activated on the transplant list as well
as the percentage of patients on the waiting list who
achieved a transplant in each centre. We assessed the
overalleffectofcentreassociatedwitheachanalysisby
including renal centre as a random effect in the risk
adjusted logistic regression model. We determined
the extent of variation between centres by using a log
likelihood ratio test that provides the change in the
value of −2LogL on inclusion of the random centre
effect.
16We usedSASv9.1foranalyses andconsidered
a 5% level to be significant.
To analyse access to the transplant list, we identified
theproportionofincidentpatientswithendstagerenal
disease in each unit who were subsequently activated
on the waiting list within two years of starting renal
replacement treatment. We considered time to activa-
tion on the waiting list to be the interval between the
start of renal replacement treatment and the date of
activationonthewaitinglist.Weestimatedthemedian
time to activation from the survivor function for
patients at each renal unit, with the event as the date
of activation and censoring at death or on 31
December 2007, whichever was earlier. We assessed
the overall effect of centre associated with time to acti-
vation by including renal centre as a variable in a risk
adjusted Cox regression model. To analyse the differ-
ences between centres in achieving a renal transplant,
we estimated the percentage of patients activated on
the waiting list who received a renal transplant within
two years of being activated (conversion efficiency).
We analysed separately the conversion efficiency for
receiving a transplant from a donor after brain stem
death or a donor after cardiac death/living kidney
donor.
Werepresentedtheresultsforeachoutcomeofinter-
est by using funnel plots, which provide a visual com-
parison of each centre’s performance compared with
its peers. Where relevant, we adjusted the funnel plots
for patient specific variables influencing that outcome.
The solid black straight line in each funnel plot shows
the overall average together with the 95% and 99.8%
confidence intervals, which correspond to two and
threestandarddeviations.Eachpointontheplotrepre-
sents one renal centre. With 65 centres included, for
each outcome of interest, two or three centres would
be predicted to fall between the 95% and 99.8% confi-
denceintervals(oneaboveandonebelow)andnocen-
tre should fall outside the 99.8% confidence interval.
We excluded centres with fewer than 10 patients start-
ingdialysis(n=2)orfewerthan10patientsactivatedon
the waiting list (n=6) during the study period from
representationinthe“percentageactivatedonthewait-
ing list,”“ median time to listing,” and “percentage
transplanted” funnel plots.
RESULTS
Logistic regression model analysis of patient specific
variables influencing access to the waiting list (table 1)
showed a negative association with increasing age of
recipient. The odds ratios were 0.75 (95% confidence
interval 0.61 to 0.93), 0.50 (0.41 to 0.61), 0.25 (0.20 to
0.30), and 0.11 (0.09 to 0.13) for patients in the age
Table 2 |Results of logistic regression modelling for probability of receiving transplant from
donor after brain stem death within two years of registration on waiting list
Baseline factor No Odds ratio (95% CI) P value
Age (years):
18-29 600 1 (referent) NA
30-39 853 1.13 (0.89 to 1.44) 0.32
40-49 1120 0.99 (0.78 to 1.25) 0.92
50-59 1062 0.69 (0.54 to 0.87) 0.002
60-64 426 0.44 (0.31 to 0.61) <0.001
Ethnicity:
White 2645 1 (referent) NA
Non-white 675 0.47 (0.37 to 0.59) <0.001
Missing 741 0.91 (0.75 to 1.10) 0.34
Sex:
Male 2450 1 (referent) NA
Female 1611 0.78 (0.67 to 0.91) 0.002
Primary renal diagnosis:
Non-diabetes 3309 1 (referent) NA
Diabetes 617 2.03 (1.68 to 2.46) <0.001
Missing 135 0.63 (0.38 to 1.03) 0.07
NA=not applicable.
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Fig 2 | Percentage of patients receiving a transplant from a
donor after brain stem death within two years of being
registered for transplantation. Risk adjusted for effect of
recipient’s age, sex, ethnicity, and primary renal diagnosis
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withtheagebandof18-29years.Wealsofoundanega-
tive association in patients who were non-white (odds
ratio 0.85, 0.75 to 0.97) or had missing ethnicity (0.74,
0.66to0.84)comparedwithwhiteethnicity.Aprimary
renal diagnosis of diabetes (odds ratio 0.40, 0.36 to
0.45) or “missing” (0.55, 0.43 to 0.69) was associated
with a reduced likelihood of being put on the waiting
list compared with patients with non-diabetic kidney
disease. Sex had no influence on the probability of
being activated on the waiting list.
Analysis of factors influencing the likelihood of
receiving a transplant from a donor after brain stem
death (table 2) showed that increasingage (odds ratios
0.69(0.54to0.87)and0.44(0.31to0.61)forpatientsin
age bands 50-59 and 60-64 years compared with age
band 18-29 years), non-white ethnicity (0.47, 0.37 to
0.59 compared with white ethnicity), and female sex
(0.78, 0.67 to 0.91) had negative associations. A pri-
mary renal diagnosis of diabetes (odds ratio 2.03,
1.68 to 2.46) had a positive association compared
withanon-diabetesdiagnosisforreceiptofatransplant
from a donor after brain stem death.
Similar analysis of factors influencing receipt of a
transplant from a donor after cardiac death or a living
kidney donor (table 3) showed a negative association
withincreasingage(oddsratios0.58(0.46to0.72),0.48
(0.39to0.60),0.33(0.26to0.41),and0.28(0.21to0.38)
for patients in age bands 30-39, 40-49, 50-59, and
60-64 years compared with age band 18-29 years).
Non-white ethnicity (odds ratio 0.57, 0.46 to 0.71)
and primary renal diagnosis of diabetes (0.48, 0.38 to
0.61) were also negatively associated with receipt of a
transplant from a donor after cardiac death or a living
kidney donor, but we found no association with sex.
These results suggest that non-white patients deemed
suitable for renal transplantation are less likely to
receive a transplant from either a donor after brain
stemdeathoradonoraftercardiacdeath/livingkidney
donor.
A patient starting dialysis in a non-transplanting
renal centre was less likely to be registered for trans-
plantation (odds ratio 0.85, 0.77 to 0.94) or receive a
transplant from a donor after cardiac death or a living
kidney donor (0.69, 0.59 to 0.80) compared with
patients cared for in transplanting renal centres. Once
registered for transplantation, patients in both trans-
planting and non-transplanting renal centres had an
equal chance of receiving a transplant from a donor
after brain stem death (odds ratio 1.01, 0.87 to 1.18).
We identified significant effects of centre for the
probability of being activated on the waiting list
(fig 1) (change in −2LogL=89.9, df=1, P<0.001) and
the probabilities of receiving a renal transplant from a
donor after brain stem death (fig 2) (change in
−2LogL=15.1, df=1, P<0.001) or a donor after cardiac
death/living kidney donor (fig 3) (change in
−2LogL=46.1, df=1, P=0.001). These differences per-
sisted even after adjustment for patient specific vari-
ables that were shown to affect the outcome event. As
shown, several centres fall outside the 95% and 99%
confidence intervals.
Figure 4 shows the unadjusted median time taken to
activate patients on the transplant list for each centre.
Thefunnelplotisbasedontheassumptionofanexpo-
nential distribution for time to activation. Although
this assumption is broadly consistent with the data,
the model based estimate of the national median is
greater than that observed. This leads to an unusually
large number of units falling outside the lower 99.8%
confidence limit for this national rate and perhaps too
few occurring outside the upper limit. However, the
plot highlights those centres that have significantly
longertimetoactivationbutsmallnumbersofpatients
on the waiting list. A risk adjusted analysis of time to
activation identified a significant effect of centre
Table 3 |Logistic regression modelling for probability of receiving transplant from donor after
cardiac death or living kidney donor within two years of registration on waiting list
Baseline factor No Odds ratio (95%CI) P value
Age (years):
18-29 600 1 (referent) NA
30-39 853 0.58 (0.46 to 0.72) <0.001
40-49 1120 0.48 (0.39 to 0.60) <0.001
50-59 1062 0.33 (0.26 to 0.41) <0.001
60-64 426 0.28 (0.21 to 0.38) <0.001
Ethnicity:
White 2645 1 (referent) NA
Non-white 675 0.57 (0.46 to 0.71) <0.001
Missing 741 0.88 (0.72 to 1.06) 0.18
Sex:
Male 2450 1 (referent) NA
Female 1611 0.99 (0.85 to 1.14) 0.85
Primary renal diagnosis:
Non-diabetes 3309 1 (referent) NA
Diabetes 617 0.48 (0.38 to 0.61) <0.001
Missing 135 1.79 (1.24 to 2.59) 0.002
NA=not applicable.
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Fig 3 | Percentage of patients receiving a transplant from a
donor after cardiac death or living kidney donor within two
years of being registered for transplantation. Risk adjusted for
effect of recipient’s age, sex, ethnicity, and primary renal
diagnosis
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with the longest unadjusted waiting times also had the
longest risk adjusted waiting times.
DISCUSSION
The main finding of our study is an effect of renal cen-
tre on patients’ access to the national renal transplant
waiting list—in the time taken to activate patients on
the waiting list and in the receipt of transplantation
once activated on the waiting list—and these differ-
ences cannot be explained by patient related factors
(case mix). The patient related factors influencing
access to the waiting list or receipt of transplantation
identified in our study are consistent with those in pre-
viously published work. Inter-centre differences were
more pronounced for access to transplants from
donors after cardiac death and living kidney donors
andthetimetakentoactivatepatientsonthetransplant
list, outcomes that are often predominantly influenced
by individual centres’ practices and policies.
Strengths and limitations of study
Although previously published literature clearly high-
lighted patient specific variables that influence access
torenaltransplantation,othernationalrenalandtrans-
plant registries have not been able to describe differ-
ences at the level of the centre. The strength of this
study is in the absence of introduction of potential
bias by recruiting all incident patients starting renal
replacement treatment. In addition, no patients were
lost to follow-up. Lack of comprehensive comorbidity
dataonallpatientsisapotentialweaknessofourstudy.
Intheabsenceofcomprehensivepatientleveldataper-
mitting definitive adjustment for case mix, our results
need to be interpreted with caution, as patient related
factors other than those analysed as part of the study
may be important in influencing access to renal trans-
plantation.Somecentresmaytakeon“sicker”patients
with higher comorbidity, explaining some of the
observed inter-centre variability. However, a recent
analysis from the UK Renal Registry reporting on
one year mortality in incident renal replacement treat-
ment patients from the same study period identified
muchlessvariabilityinpatients’survival,
17andcentres
performing less well on the survival analysis were not
the same as the centres outside the lower 99.8% confi-
dencelimitintheanalysisofaccesstotransplant.Even
though not conclusively established as part of our
study,thissuggeststhatfactorsotherthancomorbidity
may exert a significant influence on the probability of
patientsstartingrenalreplacementtreatmentaccessing
the transplant waiting list or receiving a renal trans-
plant in the UK. Many factors within and outside of
thecentre’scontrolwillinfluencetherateoftransplan-
tation from donors after brain stem death. For exam-
ple, the change to the national kidney allocation
scheme in April 2006, after which time both kidneys
ratherthanjustonefromeachdonorwereallocatedon
a national basis, as well as the increased priority given
to time on the waiting list to determine organ alloca-
tion,willaffectcentres’transplantrates.Thesechanges
were introduced to improve the chances of ethnic
minorities and other long waiting patients receiving a
kidney from a donor after brain stem death, among
other reasons. Our analysis adjusts for ethnicity over
the entire studyperiod, but adjustment for the effect of
all of the changes in the allocation scheme on centre
specific transplant rates before and after April 2006
would not be possible.
Comparison with other studies
Two previous studies have attempted to explore the
potential for variations in access to transplantation in
the UK. The study by Oniscu et al was similar to our
study in that it included incident patients starting renal
replacement treatment and assessed patient level and
centre level variables influencing access to waiting list
activationaswellasreceiptofatransplant.
13However,
thisstudywasrestrictedtopatientsinScotlandandwas
fromanerainwhichpatientsdeclaredbrainstemdead
werethepredominantsourceofdonororgans.Dudley
et al reported on point prevalence analysis and
included patients from 41 renal units in England and
Wales.
14Thisstudyincludedalargenumberofpatients
and also assessed the influence of factors such as social
deprivation on access to the transplant waiting list.
Pointprevalenceresultsfromthatstudycouldbeinflu-
encedbyshorttermfluctuationsinnumbersofpatients
and selective enrichment of the pool of prevalent
patientswithpatientsdeemedunsuitablefortransplan-
tation,aswellasbyindividualcentres’transplantrates.
For these reasons, point prevalence data should be
interpreted with caution. Neither of the above studies
included analysisof time taken to placepatients onthe
waiting list.
Policy implications
The finding that certain patient related variables such
as increasing age have a negative association with
access to transplantation is understandable, as the
No on waiting list
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Fig 4 | Median time to transplant listing after start of dialysis.
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with age. However, the effect on access to transplanta-
tionoffactorssuchassexandethnicityismoredifficult
to understand. The importance given to HLA match-
inginthenationalallocationprotocolatthetimeofthis
study would have favoured a predominantly white
donor pool being matched with white recipients,
which may explain the effect of ethnicity on this out-
come. We have not analysed the interplay between
factors such as social deprivation and ethnicity and
whether the observed differences based on ethnicity
are likely to persist after adjustment for social depriva-
tion and varying comorbidity burden in different eth-
nic groups. One possible explanation for the observed
disparity between the sexes in receipt of a transplant
from a donor after brain stem death could be preg-
nancy related HLA sensitisation in women, which in
turn will limit offers of organs. The higher proportion
of patients with diabetes receiving a transplant corre-
sponds to an increase in the number of simultaneous
kidney-pancreas transplants done during the study
period, as the allocation algorithm prioritised dual
organ recipients.
Moreimportantly,ourstudyhighlightsthepresence
of a significant effect of centre in access to transplanta-
tion, even after correction for the relevant patient
related variables. However, concluding that centres
with a lower proportion of patients on the waiting list
areinsomewayperforminglesswellwouldbesimplis-
tic.Suchcentrescouldbechoosingpatientsmorecare-
fully to ensure that the scarce resource of donated
organs is appropriately targeted to patients who are
likelytobenefitthemost.Centreswiththehighestpro-
portionofpatientsonthewaitinglistmaybeincluding
patients who have a higher risk of peri-operative mor-
bidity or mortality and hence may have inferior post-
transplantoutcomes.Thiswouldrepresentsuboptimal
use of the scarce resource of donated organs, but the
lackofaneffectofcentreonpost-transplantsurvivalof
patients and grafts argues against this explanation
(www.uktransplant.org.uk/ukt/statistics/centre-speci
fic_reports/kidney_centre-specific_reports.jsp). For
thesereasons,intheabsenceofobjectiveguidancedic-
tating inclusion and exclusion thresholds to determine
access to transplantation for patients starting renal
replacement treatment, prescribing the minimum per-
centage of patients who should be activated on the
renal transplant waiting list in every centre would be
difficult. However, significant inter-centre differences
should not exist in the time taken to activate suitable
patientsfortransplantation orin receipt ofa transplant
once on the waiting list, especially for transplantation
from donors after cardiac death or living kidney
donors,ascentres’practicepatternsarepredominantly
responsiblefortheseoutcomes.Bestpracticeidentified
in the better performing centres needs to be dissemi-
nated to all centres to enable equity of access to trans-
plantation across the UK.
Conclusions
Further work needs to be done to determine whether
the observed differences in centres’ performance are
duetovariationsinavailabilityofresourcesorbecause
certaincentreshavemoreorganisedandefficientpath-
ways for patients. A qualitative analysis of centres’
practices that act as enablers or barriers for efficient
progression of a patient with a new diagnosis of severe
renal impairment through to receiving a renal trans-
plant will result in more uniform access to renal trans-
plantation irrespective of where patients start their
renal replacement treatment. The development of a
survival probability tool or more sophisticated tools
to estimate gain of quality adjusted life years would
enable the development and implementation of more
objective guidance for patients on the potential bene-
fits of renal transplantation.
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